The good news for device industry executives assessing election outcomes, is that a new balance of power in Congress, with Democrats taking over the House while Republicans strengthen their hold in the Senate, likely won't lead to many dramatic change in policy for FDA or reimbursement.
The agency did lose several strong supporters in Congress who have sponsored, or helped shepherd, medtech-friendly legislation such as device...